|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
The Day In Review: Biotech Gives Some Back
10/19/2005 5:09:43 PM
May 31, 2005 After 3-day holiday weekend, investors did not return to Wall Street in a celebratory mood. Given the gains in the stock market during May, a weaker-than-expected Chicago PMI report was enough to convince traders to take some profits, with all major averages trading lower throughout the day. The Centient Biotech 200 moved almost 18 points lower to 3363.26, a .53% loss. Genentech reported more good news about its blindness drug, Lucentis, Idenix moved its Hepatitis C drug further along the clinical path, La Jolla put some hope into its lupus treatment, Renovis signed a pact with Pfizer, and Qiagen bought artus for $39 million. More details...
|
|
|
|
|
|
|
|
|
|
|